Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 328 publications
Evaluation of the efficacy and cost-effectiveness of safinamide versus rasagiline: a systematic review.
Journal: Journal of comparative effectiveness research
Published: August 14, 2025
Targeting MAO-B selectivity: computational screening, docking, and molecular dynamics insights.
Journal: SAR and QSAR in environmental research
Published: August 13, 2025
Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation.
Journal: Analytical methods : advancing methods and applications
Published: July 23, 2025
Efficacy of Safinamide in Early-Stage Parkinson's Disease: A Pilot Evaluation of Motor Symptom Improvement.
Journal: Journal of movement disorders
Published: July 08, 2025
Evaluation of novel selective MAO-B inhibitors using immobilized enzymes on magnetic beads.
Journal: Journal of pharmaceutical and biomedical analysis
Published: July 06, 2025
Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study.
Journal: Parkinsonism & related disorders
Published: June 24, 2025
Design, synthesis, and biological evaluation of highly potent and selective hMAO-B inhibitors featuring a tetrahydrobenzo[f][1,4]oxazepine core.
Journal: European journal of medicinal chemistry
Published: June 18, 2025
Expert perspectives on the use of safinamide for Parkinson's disease in Portugal: insights from a Portuguese Delphi Consensus.
Journal: Journal of comparative effectiveness research
Published: June 06, 2025
Eco-Friendly Simultaneous Quantification of Domperidone and Safinamide by Spectral Resolution using deconvoluted Synchronous Fluorescence: Application to Spiked Human Plasma.
Journal: Luminescence : the journal of biological and chemical luminescence
Published: May 29, 2025
Comparative efficacy and safety of irreversible (rasagiline) and reversible (safinamide) monoamine oxidase inhibitors as add-on therapy for Parkinson's disease.
Journal: Journal of neurology
Published: May 26, 2025
Effect of Safinamide on Non-Motor Symptoms and Quality of Life in Parkinson's Disease Patients According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose.
Journal: Brain sciences
Published: May 23, 2025
Use of safinamide for treatment of Parkinson disease: real-world data from Spain.
Journal: Drugs in context
Published: May 22, 2025
Last Updated: 10/31/2025